Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-16 Purchase |
2021-11-18 4:24 pm |
enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO |
2,000 | $7.87 | $15,740 | 5,736 (Direct) |
View |
| 2021-08-25 Purchase |
2021-08-27 3:19 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director |
1,300 | $7.7 | $10,010 | 4,842 (Direct) |
View |
| 2021-06-16 Purchase |
2021-06-21 7:16 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Gray Robert Director |
2,000 | $6.25 | $12,500 | 5,572 (Direct) |
View |
| 2021-05-21 Purchase |
2021-05-25 5:15 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Glickman Marc H. SVP & Chief Medical Officer |
1,600 | $5.9 | $9,440 | 1,600 (Direct) |
View |
| 2021-05-18 Purchase |
2021-05-19 8:20 pm |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer |
3,000 | $5.47 | $16,410 | 3,736 (Direct) |
View |
| 2021-05-17 Purchase |
2021-05-19 8:18 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Duhay Francis Director |
9,492 | $5.33 | $50,592 | 13,160 (Direct) |
View |
| 2020-06-11 Sale |
2020-10-01 9:25 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Biodyne Holding S.A. Former 10% Owner |
1,950,000 | $0.40361 | $787,036 | 1,405,433 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-08 1:43 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Biodyne Holding S.A. 10% Owner |
225,583 | $0.32951 | $74,331 | 3,355,433 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-13 Exercise |
2021-09-15 9:50 pm |
N/A N/A |
Hancock Jaffe Laboratories Inc. | HIJI | Jenusaitis Matthew Director |
1,042 | $0 | 7,968 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 9:50 pm |
N/A N/A |
Hancock Jaffe Laboratories Inc. | HIJI | Gray Robert Director |
1,042 | $0 | 8,698 (Direct) |
View |
| 2020-07-18 Option Award |
2021-02-23 5:21 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Glynn Craig Chief Financial Officer |
328,000 | $0 | 4,324 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:59 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Duhay Francis Director |
5,673 | $0 | 5,673 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:58 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director |
5,673 | $0 | 5,673 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:57 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Shrivastava Sanjay Director |
5,673 | $0 | 5,673 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:56 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer |
838,000 | $0 | 838,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:56 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Gray Robert Director |
5,673 | $0 | 5,673 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:56 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Glickman Marc H. SVP & CMO |
406,000 | $0 | 406,000 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:58 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Glickman Marc H. SVP & CMO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:57 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Shrivastava Sanjay Director |
162,500 | $0 | 197,500 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:56 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Duhay Francis Director |
162,500 | $0 | 207,228 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:56 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Gray Robert Director |
162,500 | $0 | 178,250 (Direct) |
View |
| 2020-07-18 Other |
2020-07-21 9:55 pm |
2018-04-26 2028-04-26 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,080,207 | $0 | 1,080,207 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:55 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,080,207 | $0 | 1,080,207 (Direct) |
View |
| 2020-07-18 Option Award |
2020-07-21 9:55 pm |
N/A 2030-07-18 |
Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |